BioSpace News Archive

Genetown

Memorial Sloan Kettering Selects NeuroLogica Mobile CT for Brachytherapy Imaging

Prestigious Cancer Center Deploys NeuroLogica BodyTom in Radiation Oncology to Help Enhance Therapy Precision

January 9, 2020
·
3 min read
ProBioGen Inks Next Commercial GlymaxX® License with Roche

ProBioGen AG has signed a commercial license agreement with Roche for applying ProBioGen’s proprietary GlymaxX® technology to boost the antibody’s ADCC anti-tumor activity.

January 9, 2020
·
1 min read
Business

Karl Naegler joins Wellington Partners as Managing Partner

Wellington Partners, a leading European venture capital firm investing in early- and growth-stage life science companies, announced that Dr. Karl Naegler joined Wellington as a Managing Partner on January 1, 2020.

January 9, 2020
·
3 min read
Atriva Therapeutics to take part in three major conferences in San Francisco, USA, in the upcoming week

Atriva Therapeutics GmbH, a clinical stage biopharmaceutical company pioneering the development of host-targeting antiviral therapies, announces its participation in three upcoming conferences in San Francisco, CA, USA, in January.

January 9, 2020
·
2 min read
Job Trends

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

Findings may create immunotherapy options for lymphomas caused by CREBBP mutations

January 9, 2020
·
3 min read
Drug Development

Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201

Data show superior efficacy after four weeks of treatment and more rapid onset of action for CBP-201 compared with data from studies of current standard of care therapy for AD

January 9, 2020
·
7 min read
Policy

HHS Awards Sanofi $226 Million to Expand Flu Vaccine Manufacturing Capabilities

The site location is in Swiftwater, Pennsylvania.

January 9, 2020
·
3 min read
·
Mark Terry
Business

AbbVie Sets up Allergan Aesthetics Ahead of Finalizing its $63 Billion Acquisition

While Allergan and AbbVie prepare to complete their $63 billion merger later this year, plans are being laid out for a new, stand-alone company called Allergan Aesthetics that will include Botox as a tent pole.

January 9, 2020
·
3 min read
·
Alex Keown
Drug Development

Regeneron’s FOP Disease Treatment Reduces New Lesions by 90%

Fibrodysplasia ossificans progressive (FOP disease) treatment is almost here and it is showing promising results. This article provides deep insights into it.

January 9, 2020
·
3 min read
·
Alex Keown
Policy

Is the FDA Approving Drugs Too Quickly?

A recent study questions if the FDA and other regulatory agencies worldwide rush certain approvals, particularly at the end of the year in a kind of “desk-clearing” activity.

January 9, 2020
·
4 min read
·
Mark Terry